DDN (dendrin) is a pro-apoptotic protein primarily localized to cellular compartments including the cytoplasm, cytosol, and nucleoplasm 1. Its primary function is to promote apoptosis of kidney glomerular podocytes, which are specialized cells essential for blood ultrafiltration and protein retention. DDN functions as a protein-binding molecule involved in regulating cell projection dynamics. Recent genetic studies have identified DDN as a co-located gene with SMAD-3 in pathways linking osteoporosis to osteoarthritis risk 1. The gene appears relevant to musculoskeletal and renal diseases through its role in cellular apoptosis regulation. In the context of osteoporosis and osteoarthritis, Mendelian randomization analyses demonstrated that genetically predicted low bone mineral density was causally associated with increased osteoarthritis risk, with DDN identified as a prominent gene in the shared biological pathways between these conditions 1. However, detailed molecular mechanisms of DDN-mediated podocyte apoptosis and specific clinical applications remain incompletely characterized in the provided literature. Further research is needed to elucidate DDN's precise mechanistic role in glomerular disease pathogenesis and its therapeutic potential.